Comparative Effect of Myo-inositol With That of D-chiro-inositol on Insulin Resistance in Infertile Women With Polycystic Ovary Syndrome (PCOS).

NCT07453680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-03-06

No results posted yet for this study

Summary

This randomized controlled trial was conducted in the Department of Reproductive Endocrinology and Infertility, BSMMU.A total of 80 infertile women ofPCOS withinsulinresistanceparticipatedinthestudyandwere randomly allocated into 2 groups. One group was treated with tab. Myoinositol (MI) 750 mg thrice daily and other group with D-chiro-inositol (DCI) 500 mg once daily for 3 months. After 3 months, follow up fasting blood sugar, fasting insulin and HOMA-IR were measured

Conditions

  • PCOS (Polycystic Ovary Syndrome)

Interventions

DIETARY_SUPPLEMENT

Tab Myo-inositol 750mg

Tab Myo-inositol 750mg 3 times daily for 3 months

DIETARY_SUPPLEMENT

D-chiro-inositol 500mg

Cap D-chiro-inositol 500 mg once daily for 3 months

Sponsors & Collaborators

  • Bangladesh Medical University

    collaborator OTHER
  • Mst.Sumyara Khatun

    lead OTHER

Principal Investigators

  • Shakeela Ishrat, FCPS · Bangladesh Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07453680 on ClinicalTrials.gov